Miastenia Gravis: su manejo en situaciones especiales

1. AAEM Quality Assurance Committee, American Association Electrodiagnostic medicine. Practice parameter or repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement. Muscle Nerve, 2001;24:1236-1238.

2. Andews PI, Sanders DB. Juvenile myasthenia gravis. In Neuromuscular Disorders of infancy, Childhood, and Adolescence. Ed Jones HR, DeVivo DC, Darras GT, Butterworth Heinemann, Boston. 2002. pp 575-597.

3. Anlar B, Senbil N, Kose G, et al. Serological follow-up in juvenile myasthenia gravis: clinical and acetylcholine receptor antibody status of patients followed for at least 2 years. Neuromuscular Dis. 2005;15:355-357.

4. Chan KH, Lachance D, lennon V. Definition and frequency of seronegativity in generalized myasthenia gravis acquired in adulthood. Neurology. 2006;66 (Suppl 2):A256.

5. Drachman DB, Jones RJ, Brodksky RA. Treatment of refractory myasthenia. “Rebooting”  the immune system with high-dose cyclophosphamide. Neurology: 2002;58 (Suppl 3):A328-329.

6. Engel AG. Congenital myasthenia syndromes. In Neuromuscular function Disorders. Series 3/e, ed Engel AG. Elsever, 2007.

7. Evoli A, Tonali PA, Padua I, Monaco ML,  Scuderi F, Batocchi AP , Marino M, Bartoccioni E. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain, 2003;126:2304-2311.

8. Farrugia ME, Robson MD, Clover I, et al. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody associated myasthenia gravis. Brain; 2006;129:1481-1492.

9. Ferrero S, Pretta S, Nicoletti A, et al. Myasthenia gravis management issues during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2005; 121:129-138.+